Status:
UNKNOWN
The Monocyte Subsets in Obese Patients With and Without Metabolic Syndrome
Lead Sponsor:
University Hospital, Ioannina
Conditions:
Obesity
Metabolic Syndrome
Eligibility:
All Genders
18-70 years
Brief Summary
Obesity is associated with a chronic low-grade inflammation characterized by macrophage infiltration in adipose tissue that induces insulin resistance and the appearance of metabolic syndrome (MS). Th...
Eligibility Criteria
Inclusion
- \-
Exclusion
- Age less than 18 years old, pregnancy, breast feeding, kidney disease, liver disease, gastrointestinal disease, malignancy, any endocrine disorder or metabolic disease, other than obesity or type 2 diabetes mellitus (T2DM), alteration of body weight (BW) by up of 5% of the initial BW during the last 3 months, any state of stress or systemic inflammation and taking any of the following drugs, within 3 weeks prior to the start of the study: hypolipidemic agents, antidiabetics, drugs for weight loss, nonsteroidal antiinflammatory drugs, glucocorticoids.
Key Trial Info
Start Date :
July 25 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03241394
Start Date
July 25 2017
End Date
September 15 2017
Last Update
August 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Ioannina
Ioannina, Greece